Tumor dosimetry in radioimmunotherapy: Methods of calculation for beta particles
Journal Article
·
· Medical Physics; (United States)
- University of Nebraska Medical Center, Department of Radiology, Omaha, Nebraska 68198-1045 (United States)
- Hamilton Regional Cancer Centre, Ontario Cancer Treatment and Research Foundation and McMaster University, Hamilton, Ontario (Canada)
Calculational methods of beta-particle dosimetry in radioimmunotherapy (RIT) are reviewed for clinical and experimental studies and computer modeling of tumors. In clinical studies, absorbed-dose estimates are usually based on the [ital in]-[ital vivo] quantitation of the activity in tumors from gamma camera images. Because of the limited spatial resolution of gamma cameras, clinical dosimetry is necessarily limited to the macroscopic level (macrodosimetry) and the MIRD formalism for absorbed-dose calculations is appropriate. In experimental RIT, tumor dimensions are often comparable to or smaller than the beta-particle range of commonly used radionuclides (for example, [sup 131]I, [sup 67]Cu, [sup 186]Re, [sup 188]Re, [sup 90]Y) and deviations from the equilibrium dose must be taken into account in absorbed-dose calculations. Additionally, if small tumors are growing rapidly at the time of RIT, the effects of tumor growth will need to be included in absorbed-dose estimates. In computer modeling of absorbed-dose distributions, analytical, numerical, and Monte Carlo methods have been used to investigate the consequences of uniform and nonuniform activity distributions and the effects of inhomogeneous media. Measurements and calculations of the local absorbed dose at the multicellular level have shown that variations in this dose are large. Knowledge of the absorbed dose is essential for any form of radiotherapy. Therefore, it is important that clinical, experimental, and theoretical investigations continue to provide information on tumor dosimetry that is necessary for a better understanding of the radiobiological effects of RIT.
- DOE Contract Number:
- FG02-91ER61195
- OSTI ID:
- 6650446
- Journal Information:
- Medical Physics; (United States), Journal Name: Medical Physics; (United States) Vol. 20:2; ISSN 0094-2405; ISSN MPHYA6
- Country of Publication:
- United States
- Language:
- English
Similar Records
Macrodosimetry and microdosimetry in radioimmunotherapy. Final report, July 15, 1989 -- July 14, 1992
Macrodosimetry and microdosimetry in radioimmunotherapy
Tumor dosimetry for Cu-64 and Cu-67-labeled Mab 1A3 for radioimmunotherapy
Technical Report
·
Sat Nov 30 23:00:00 EST 1991
·
OSTI ID:145670
Macrodosimetry and microdosimetry in radioimmunotherapy
Technical Report
·
Wed Jan 31 23:00:00 EST 1990
·
OSTI ID:6998879
Tumor dosimetry for Cu-64 and Cu-67-labeled Mab 1A3 for radioimmunotherapy
Journal Article
·
Mon May 01 00:00:00 EDT 1995
· Journal of Nuclear Medicine
·
OSTI ID:441632
Related Subjects
560101* -- Biomedical Sciences
Applied Studies-- Radiation Effects-- Dosimetry & Monitoring-- (1992-)
61 RADIATION PROTECTION AND DOSIMETRY
BETA DECAY RADIOISOTOPES
BETA DOSIMETRY
CALCULATION METHODS
DISEASES
DOSIMETRY
IMMUNOLOGY
IMMUNOTHERAPY
ISOTOPES
MEDICINE
MONTE CARLO METHOD
NEOPLASMS
NUCLEAR MEDICINE
RADIATION DOSE DISTRIBUTIONS
RADIOIMMUNOLOGY
RADIOIMMUNOTHERAPY
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
SPATIAL DOSE DISTRIBUTIONS
THERAPY
Applied Studies-- Radiation Effects-- Dosimetry & Monitoring-- (1992-)
61 RADIATION PROTECTION AND DOSIMETRY
BETA DECAY RADIOISOTOPES
BETA DOSIMETRY
CALCULATION METHODS
DISEASES
DOSIMETRY
IMMUNOLOGY
IMMUNOTHERAPY
ISOTOPES
MEDICINE
MONTE CARLO METHOD
NEOPLASMS
NUCLEAR MEDICINE
RADIATION DOSE DISTRIBUTIONS
RADIOIMMUNOLOGY
RADIOIMMUNOTHERAPY
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
SPATIAL DOSE DISTRIBUTIONS
THERAPY